Press What’s news at AbelsonTaylor Group
Select category
Health Literacy and Rare Disease
In a discussion about health literacy, MedAdNews talks to AT’s Sharlene Jenner, VP – Director of Engagement Strategy, and Mike Czuba, VP – Insights Innovation, about AbelsonTaylor’s approach to getting the right message to the right patient in the rare disease space.
Read more at Med Ad News/PharmaLive
Media Contact:
Recent Posts
The missing skill in the AI era isn’t prompting — It’s curiosity
“Curiosity is what builds judgment, and this is why AI is most powerful in the hands of curious people,” according...
In the News Read more The missing skill in the AI era isn’t prompting — It’s curiosityThe biggest barrier to AI adoption in healthcare isn’t regulation. It’s trust.
As AI adoption accelerates, trust may be the real differentiator. In MedAdNews, Janet Barker-Evans, Chief Creative Officer of AbelsonTaylor Group,...
In the News Read more The biggest barrier to AI adoption in healthcare isn’t regulation. It’s trust.From Insights to Action: The Bridge Between Strategy and Execution
“Having access to more information doesn’t automatically lead to better decisions—you need judgment,” says AbelsonTaylor Group’s Amy Restko, VP, Engagement...
In the News Read more From Insights to Action: The Bridge Between Strategy and ExecutionConnect with us
Find out what's top of mind for the people reimagining health and wellness advertising.